Heart Failure Clinical Trials

Find Heart Failure Clinical Trials Near You

Contemporary Post-Discharge Management in Heart Failure at Home

Status: Recruiting
Location: See all (11) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to assess whether patients with acute heart failure (HF) can achieve the same level of HF-therapies by digital follow-up at home as compared to hospital visits according to the STRONG-HF strategy. Patients admitted to hospital with acute HF will be enrolled and randomized to either follow-up at the hospital out-patient clinic or digital follow-up at home.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Hospital admission within the 72 hours prior to screening for acute HF.

• NT-proBNP ≥ 1,000 pg/mL measured during the hospitalization

• Systolic blood pressure ≥ 100 mmHg and of heart rate ≥ 60 bpm within 24 hours before randomization

• Serum potassium ≤ 5.0 mEq/L (mmol/L).

• ≤ ½ the optimal dose of ACEi/ARB/ARNi or beta-blocker or MRA.

• Written informed consent to participate in the study.

Locations
Other Locations
Norway
Ålesund Hospital
RECRUITING
Ålesund
Sørlandet Sykehus
RECRUITING
Arendal
Drammen Hospital, Vestre Viken HF
RECRUITING
Drammen
Innlandet sykehus
RECRUITING
Hamar
Levanger Sykehus
RECRUITING
Levanger
Akershus University Hospital
RECRUITING
Lørenskog
Østfold Hospital
RECRUITING
Moss
Oslo University Hospital
RECRUITING
Oslo
Stavanger University Hospital
RECRUITING
Stavanger
Tønsberg Sykehus
RECRUITING
Tønsberg
Tromsø University Hospital
RECRUITING
Tromsø
Contact Information
Primary
Peder L Myhre, MD, PhD
p.l.myhre@medisin.uio.no
+47 93025644
Backup
Henrik Schirmer, MD, PhD
henrik.schirmer@medisin.uio.no
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 450
Treatments
Experimental: Home care
Follow-up and management of HF medications at home visits after 1, 2, 3 and 6 weeks performed by telecommunication led by HF nurses in close communication with physician at the institution. Around week 2 a single visit to the primary care physician's office is required.
Active_comparator: Hospital care
Follow-up and management of HF medications provided by specialists at the participating institutions' outpatient clinics after 1, 2, 3 and 6 weeks. (Same as the high-intensity arm in STRONG-HF)
Related Therapeutic Areas
Sponsors
Collaborators: Oslo University Hospital
Leads: University Hospital, Akershus

This content was sourced from clinicaltrials.gov